Address Hidden Threat of Amputation Related to Peripheral Artery Disease (PAD)
TITUSVILLE, N.J. – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives. Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial focus on reaching Black Americans, who are more than twice as likely to be impacted by PAD.1 Janssen has joined forces with leading professional associations, healthcare systems and community organizations to advance equitable care for individuals and communities placed at an increased risk for cardiovascular disease in the U.S.
‘Save Legs. Change Lives. sets in motion a vision for more relevant, trusted and inclusive care for everyone affected by PAD,’ said Avery Ince, M.D., Ph.D., Vice President, Medical Affairs, Janssen Cardiovascular & Metabolism, Janssen Scientific Affairs, LLC. ‘As part of Johnson & Johnson, Janssen believes that major corporations have the power – and therefore the responsibility – to tackle pressing health challenges and make good health a reality for all people. We hope our efforts will inspire action to reduce amputations among people living with PAD.’